New Key Statistics Module, Z-Score and F-Score
SHSE:688443 Key Ratios
Market Cap ¥ M | 9,647.35 |
Enterprise Value ¥ M | 7,873.90 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 4.10 |
Price/Sales | 715.48 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 13.00 |
EPS (TTM) ¥ | -2.13 |
Beneish M-Score | 72.27 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -10.48 |
EV-to-EBITDA | -10.48 |
PEG | -- |
Shares Outstanding M | 366.68 |
Net Margin (%) | -5,748.36 |
Operating Margin % | -6,062.76 |
Pre-tax Margin (%) | -5,748.36 |
Quick Ratio | 18.62 |
Current Ratio | 19.02 |
ROA % (ttm) | -22.44 |
ROE % (ttm) | -29.40 |
ROIC % (ttm) | -140.98 |
Dividend Yield % | -- |
Altman Z-Score | 5.45 |
SHSE:688443 Number of Guru Trades
SHSE:688443 Volume of Guru Trades
Gurus Latest Trades with SHSE:688443
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:688443 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Chongqing Genrix Biopharmaceutical Co Ltd Insider Transactions
No Available Data